Logo

American Heart Association

  2
  0


Final ID: MDP515

Diastolic Dysfunction And The Risk Of Stroke And Major Bleeding

Abstract Body (Do not enter title and authors here): Background: Diastolic dysfunction (DD) is associated with adverse cardiovascular outcomes including atrial fibrillation. Whether DD is independently associated with incident ischemic stroke/transient ischemic attack (TIA) and with bleeding events is not well established.
Aims: To examine the association of presence and severity of DD with the risk of incident ischemic stroke/TIA and major bleeding.
Methods: A total of 219,667 patients who underwent at least one echocardiogram between 2010 and 2022 at a large academic institution and were followed for at least 3 months were included. Patients with prior history of stroke or TIA (n=21,505, 10%) were excluded. Smart key-phrase search was applied to echocardiographic reports to classify patients into 4 groups, based on the most severe DD assessment: Normal (n=113,265), grade I (n=21,981), grade II (n=7,215), and grade III (n=1,627). Patients in whom the presence of DD could not be determined (n=54,074) were excluded. The final study cohort (n=144,088) was followed to the endpoint of hospital admission for ischemic stroke/TIA or for major bleeding.
Results: Over a median follow-up of 3.4 years, 3482 (2.4%) patients were hospitalized for stroke/TIA and 6994 (4.9%) for major bleeding. After adjusting for several confounding variables (Table), DD remained a strong predictor of incident stroke/TIA (hazard ratio (HR)=1.34 per grade increase in DD, p<0.001, Figure) and of major bleeding (HR=1.32 per grade increase in DD, p<0.001, Figure). These results were similar in patients with (n=11,508, 8%) or without prior history of atrial fibrillation.
Conclusions: Patients with DD have a heightened risk of ischemic cerebrovascular accidents and major bleeding independent of the presence of atrial fibrillation. These risks escalate with the severity of DD. DD should be considered when counseling patients regarding their risk profile and management options.
  • Kundrick, John  ( UPMC , Pittsburgh , Pennsylvania , United States )
  • Shalaby, Alaa  ( Univ of Pittsburgh School of Med , Pittsburgh , Pennsylvania , United States )
  • Estes, Nathan  ( UPMC , Pittsburgh , Pennsylvania , United States )
  • Jain, Sandeep  ( UNIV PITTSBURGH , Wexford , Pennsylvania , United States )
  • Saba, Samir  ( UPMC , Pittsburgh , Pennsylvania , United States )
  • Saba, Karina  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Naniwadekar, Aditi  ( UPMC , Pittsburgh , Pennsylvania , United States )
  • Singla, Virginia  ( UPMC , Pittsburgh , Pennsylvania , United States )
  • Mulukutla, Suresh  ( University of Pittsburgh Medical Center , Wexford , Pennsylvania , United States )
  • Thoma, Floyd  ( UPMC PRESBYTERIAN-SHADYSIDE , Pittsburgh , Pennsylvania , United States )
  • Bhonsale, Aditya  ( University of Pittsburgh Med Cen , Pittsburgh , Pennsylvania , United States )
  • Kancharla, Krishna  ( UPMC , Pittsburgh , Pennsylvania , United States )
  • Voigt, Andrew  ( UPMC , Pittsburgh , Pennsylvania , United States )
  • Author Disclosures:
    John Kundrick: DO NOT have relevant financial relationships | Alaa Shalaby: No Answer | Nathan Estes: DO NOT have relevant financial relationships | Sandeep Jain: DO have relevant financial relationships ; Research Funding (PI or named investigator):Abbott:Active (exists now) ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Samir Saba: DO have relevant financial relationships ; Consultant:Medtronic (Any division):Active (exists now) ; Researcher:Abbott:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) | Karina Saba: DO NOT have relevant financial relationships | Aditi Naniwadekar: No Answer | Virginia Singla: No Answer | Suresh Mulukutla: DO have relevant financial relationships ; Consultant:Medtronic:Past (completed) ; Other (please indicate in the box next to the company name):Amgen (Funding for QI project):Past (completed) ; Advisor:CardioAlliance:Active (exists now) | Floyd Thoma: DO NOT have relevant financial relationships | Aditya Bhonsale: DO NOT have relevant financial relationships | krishna kancharla: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Advisor:Varian:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) | Andrew Voigt: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Deciphering Stroke Origins: Bridging Neurology and Cardiology

Saturday, 11/16/2024 , 12:50PM - 02:15PM

Moderated Digital Poster Session

More abstracts from these authors:
High Intensity Statin Use Improved ASCVD Outcomes in Patients with Severe Hyperlipidemia in a Primary Prevention Cohort

Hallihan Cameron, Zhu Jianhui, Thoma Floyd, Nambi Vijay, Mehta Anurag, Agarwala Anandita, Marroquin Oscar, Mulukutla Suresh, Saeed Anum

Outcomes of Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and Gastrointestinal Bleeding: Insights from a Multicenter Registry

Ayub Muhammad Talha, Patel Chinmay, Gada Hemal, Bhonsale Aditya, Estes Nathan, Kancharla Krishna, Shalaby Alaa, Singla Virginia, Naniwadekar Aditi, Voigt Andrew, Saba Samir, Preisendorfer Stefan, Jain Sandeep, Wann Dan, Howard Ato, Thoma Floyd, Zhu Jianhui, Sheth Aakash, Jabbour George, Singh Madhurmeet

You have to be authorized to contact abstract author. Please, Login
Not Available